Comparative Study on the Efficacy and Safety of Tumor Resection in Vitrectomy for Retinal Vasoproliferative Tumors

Table 2

Baseline characteristics of patients.

Case	Sex/Age/Eye	SD	RT	Symptom	DS (months)	BCVA (logMAR)			FT (months)	AL (mm)	RE (D)	IOP (mmHg)	FD	Tumors
						Pre-op	Post-op 6m	Last						Ty.	Pd	B	N	L	S (PD)
1	F/55/R	—	no	DV	36	0.7	0.15	0.2	19	21.61	—	16.6	EMM	P	no	no	1	IT	2
2	F/42/R	Ht	no	Fr; M	8	0.3	0.3	0.2	8	22.5	−0.25	14.0	EMM	P	no	no	1	IT	4
3	F/42/L	PT	no	DV	12	0.1	0.05	0	38	23.92	0.25	16.4	EMM; TRD	P	no	no	1	IN	2
4	F/58/R	CE	no	DV; RE	8	2	1.7	1.3	31	23.14	5.00	10.3	EMM; Uv; REx; SRF	S	yes	no	1	T	2
5	M/65/R	—	no	DV	1	2.6	0	0	—	22.99	—	7.9	VH (4)	P	no	no	1	IT	0.5
6.1	F/42/L	Ht	no	DV; Fr	0.25	0.3	1.3	1.3	8	23.32	0.00	13.9	Uv; REx; SRF	S	yes	no	1	IT	2
7.1	F/64/R	Ht	no	DV; Fr; FL	6	0.7	1	1	6	22.84	0.50	16.3	TRD: EMM	P	no	no	1	ST	6
7.2	F/64/L	Ht	no	DV	3	0.15	0.1	0.1	6	22.52	0.00	20.8	EMM	P	yes	no	1	T	2
8	F/60/L	—	no	DV	36	0.2	0.1	0.1	17	23.87	0.25	12.3	MH; EMME: TRD	P	yes	no	1	IT	4
9	F/43/R	—	no	Fr	0.5	0	0	0	6	23.57	0.00	11.7	VH (1)	P	yes	no	1	T	2
10	M/47/L	AS	yes	DV	12	1.7	0.1	0.1	23	23.5	−1.00	10.9	VH (3); EEM	P	yes	no	1	IT	2
11	M/69/R	Ht	yes	DV	2	2.3	0.4	0.5	5	23.92	1.50	13.4	VH (4)	P	no	no	1	IN	—
12	F/65/L	—	yes	DV; Fr	1	0.05	0.1	0.2	6	22.61	−0.25	14.9	VH (1)	P	yes	yes	1	T	3
13	F/41/L	—	yes	DV; Fr	4	1	0.4	0.7	15	22.91	−3.25	10.1	VH (1); EEM; SRF; Uv; Rex	S	yes	yes	1	IT	2.5
14	M/37/L	—	yes	DV; M	1	0.5	0.1	0.1	6	24.67	−1.75	12.4	EMM; Uv	P	yes	no	1	ST	1.5
15	F/34/L	—	yes	DV; M	2	1.85	0.4	0.4	6	23.55	0.00	19.4	VH (1); EEM; Uv; TRD	S	yes	yes	1	IN	2
16	M/25/L	—	yes	DV; Fr	4	0.8	0.1	0.4	39	24.05	−0.25	12.4	EMM; Uv; SRF;	S	yes	no	1	T	3
6.2	F/42/L	Ht	yes	DV; VFD	5	1.3	1	1	30	23.32	0.00	17.3	Uv; REx; SRF	S	yes	no	1	IT	2

F, female; M, male; SD, systemic disease; RT, resection of tumor; DS, duration of symptoms; BCVA, best-corrected visual acuity; Pre-op, preoperative; Post-op 6m, postoperative 6 months; last, last visit; FT, follow-up time; AL, axial length; RE, refractive error; IOP, intraocular pressure; FD, fundus disease; Ty., type; Pd, preoperative diagnosis; B, B ultrasound; N, number; L, location; S, size; PD, papillary diameter; Ht, hypertension; PT, pulmonary tuberculosis; CE, cancer of endometrium; AS, ankylosing spondylitis; Fr, floater; DV, decreased vision; VFD, visual field defect; FL, flash of light; M, metamorphopsia; RE, red eye; EMM, epimacular membrane; VH(degree), vitreous hemorrhage; Uv, uveitis; SRF, subretinal fluid; TRD, tractional retinal detachment; RRD, rhegmatogenous retinal detachment; Rex, retinal exudation; MH, macular hole; IT, infratemporal; IN, infranasal; T, temporal; ST, superotemporal.